2 results
Not approvedWill not start
To compare the EPOS guideline with the free choice treatment of the GP for acute rhinosinusitis in general practice.
Approved WMOPending
Main objective of the trial is to determine the effect of individualizing the immunosuppressive therapy based on baseline immune-risk stratification according to 2 new biomarkers (d-sp ELISPOT IFN-γ and donor/recipient HLA Eplet Mismatch), in a…